Pharmacovigilance Market Report 2026

Pharmacovigilance Market Overview

• Pharmacovigilance market size has reached to $9.64 billion in 2025 • Expected to grow to $17.41 billion in 2030 at a compound annual growth rate (CAGR) of 12.5% • Growth Driver: Research And Development Drive Growth In The Pharmacovigilance Market • Market Trend: Pharmacovigilance Market Embraces Artificial Intelligence For Enhanced Efficiency And Safety • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug's advantages outweigh its hazards, and it doesn't end once the drugs are approved. The main types of pharmacovigilance are spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining. Spontaneous reporting is by nature a passive approach to pharmacovigilance, relying entirely on the motivation of individuals to report suspected adverse drug reactions to local or national pharmacovigilance centers. The different process flows include case data management, signal detection, and risk management systems. The various service providers are in-house and contract to outsource and involve several clinical trial phases such as preclinical, phase I, phase II, phase II, and phase IV. These services are used by several end-users, including hospitals, pharmaceutical companies, and others.

What Is The Pharmacovigilance Market Growth Forecast?

The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $17.41 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to real-world data utilization growth, rising biologics and biosimilars approvals, increasing complexity of combination therapies, expansion of pharmacovigilance in emerging markets, growing focus on patient safety outcomes. Major trends in the forecast period include expansion of post-marketing surveillance activities, growing adoption of real-world evidence in safety monitoring, increasing regulatory scrutiny and compliance requirements, rising outsourcing of pharmacovigilance services, integration of multisource safety data platforms.

Global Pharmacovigilance Market Segmentation

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining 2) By Service Provider: In-House, Contract Outsourcing 3) By Process Flow: Case Data Management, Signal Detection, Risk Management System 4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV 5) By End User: Hospitals, Pharmaceutical Companies, Other End Users Subsegments: 1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals 2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies 3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs 4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies 5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

What Is The Driver Of The Pharmacovigilance Market?

The increasing research and development activities will drive the pharmacovigilance market. By investing in R&D, pharmaceutical companies can develop new and innovative drugs with improved safety profiles. Rigorous preclinical and clinical testing during the drug development process enables early identification of potential safety concerns, allowing for appropriate risk mitigation strategies to be implemented. Additionally, R&D efforts contribute to the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating the early detection of adverse drug reactions in the post-marketing phase. For instance, in 2023, according to Office for National Statistics, a UK-based, government agency, the UK government’s net spending on research and development (R&D) increased to £17.4 billion in 2023, up from £16.1 billion in 2022, marking an 8.2% rise. Therefore, the increasing research and development activities supported the growth of the pharmacovigilance industry.

Key Players In The Global Pharmacovigilance Market

Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.

Global Pharmacovigilance Market Trends and Insights

Major Companies in the pharmacovigilance market are focusing on artificial intelligence (AI) to improve efficiency. AI can help improve the efficiency and accuracy of pharmacovigilance activities, ultimately leading to better patient outcomes. By utilizing AI, pharma companies can streamline their processes, improve data management, and accelerate drug discovery, while simultaneously reducing costs and improving safety. For instance, in August 2024, the Government of India launched the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software facilitates the collection and analysis of adverse events related to medicines and medical devices, making the reporting process easier for both consumers and healthcare professionals. This initiative significantly strengthens India's pharmacovigilance infrastructure by ensuring a more comprehensive capture of safety data and enhancing drug safety monitoring. The ADRMS aims to improve the efficiency of drug safety oversight and compliance with standards, helping position India as a leader in the global pharmaceutical industry.

What Are Latest Mergers And Acquisitions In The Pharmacovigilance Market?

In January 2023, AmerisourceBergen, an American drug wholesale company, acquired Pharma Lex for an undisclosed amount. This acquisition is expected to add capabilities to the company's existing service offering, allowing the company to provide pharmaceutical and biotech companies with enhanced support and value across the product lifecycle. Pharma Lex’s Germany-based team provides true end-to-end solutions for pharmacovigilance systems and operations, as well as benefit-risk management services.

Regional Insights

North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmacovigilance Market?

The pharmacovigilance market includes revenues earned by collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmacovigilance Market Report 2026?

The pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.